Details for New Drug Application (NDA): 207314
✉ Email this page to a colleague
The generic ingredient in CYCLOBENZAPRINE HYDROCHLORIDE is cyclobenzaprine hydrochloride. There are sixteen drug master file entries for this compound. Fifty-eight suppliers are listed for this compound. Additional details are available on the cyclobenzaprine hydrochloride profile page.
Summary for 207314
Tradename: | CYCLOBENZAPRINE HYDROCHLORIDE |
Applicant: | Macleods Pharms Ltd |
Ingredient: | cyclobenzaprine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 207314
Physiological Effect | Centrally-mediated Muscle Relaxation |
Suppliers and Packaging for NDA: 207314
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 207314 | ANDA | Macleods Pharmaceuticals Limited | 33342-272 | 33342-272-09 | 60 CAPSULE in 1 BOTTLE (33342-272-09) |
CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 207314 | ANDA | Macleods Pharmaceuticals Limited | 33342-272 | 33342-272-12 | 10 BLISTER PACK in 1 CARTON (33342-272-12) / 10 CAPSULE in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 15MG | ||||
Approval Date: | Jul 22, 2024 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 30MG | ||||
Approval Date: | Jul 22, 2024 | TE: | AB | RLD: | No |
Complete Access Available with Subscription